Industry Insights
-
How To Stand Up A Hospital-Based CAR-T Manufacturing Network
10/30/2026
Estimates show that a small hospital-based, modular GMP facility can deliver more than 250 products per year with more flexibility than fully automated, integrated equipment.
-
September 2026 — CDMO Opportunities And Threats Report
10/28/2026
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.
-
An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs?
10/28/2026
FDA’s real-time CRL releases face legal and operational hurdles. Could AI-assisted redaction make transparency faster and more consistent?
-
Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty
10/22/2026
Geopolitical shocks are reshaping outsourced pharmaceutical testing. Learn how procurement teams can strengthen resilience and protect continuity.
-
Is Your Supply Chain Ready For The End Of Class VI?
10/21/2026
Revisions to USP <87> and <88> update biological reactivity testing — changes that are especially important for companies that rely on single-use technology.
-
Demonstrating Gene Therapy Potency: A Strategic Road Map
10/20/2026
Meeting regulatory expectations for phase-appropriate potency assessments for in vivo gene therapies is widely recognized as a challenge. Here's a consensus view from BioPhorum members on how to tackle it.
-
Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
10/19/2026
Connecting scientific advances with scalable manufacturing, rigorous evidence, and regulatory strategies can help bring therapies to patients.
-
When Lyophilization Fails At Scale, First Scrutinize Your Formulation
10/16/2026
When lyophilizing a challenging biologic drug product, use an integrated approach optimizing formulation and process parameters together.
-
The 5 Shifts That Could Remake Lyophilization By 2040
10/15/2026
Purdue University-based LyoHUB charts a risk-based course to modernizing freeze-drying technology for better performance and advanced modalities.
-
Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
10/12/2026
At Meeting on the Mesa 2026, industry leaders discussed what it will take to move autoimmune CAR T beyond promising clinical results.